h1

h2

h3

h4

h5
h6
001005974 001__ 1005974
001005974 005__ 20250318115459.0
001005974 0247_ $$2ISSN$$a1526-9655
001005974 0247_ $$2ISSN$$a1557-9190
001005974 0247_ $$2ISSN$$a1938-0712
001005974 0247_ $$2ISSN$$a2152-2650
001005974 0247_ $$2ISSN$$a2152-2669
001005974 0247_ $$2ISSN$$a2331-4486
001005974 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85208591342
001005974 0247_ $$2WOS$$aWOS:001427360500001
001005974 0247_ $$2datacite_doi$$a10.18154/RWTH-2025-02142
001005974 0247_ $$2doi$$a10.1016/j.clml.2024.10.001
001005974 037__ $$aRWTH-2025-02142
001005974 041__ $$aEnglish
001005974 082__ $$a610
001005974 1001_ $$aHarrison, Claire N.$$b0$$eCorresponding author
001005974 245__ $$aLongitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib$$honline, print
001005974 260__ $$aDallas, Tex.$$bCancer Information Group$$c2025
001005974 260__ $$c2024
001005974 3367_ $$00$$2EndNote$$aJournal Article
001005974 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001005974 3367_ $$2BibTeX$$aARTICLE
001005974 3367_ $$2DRIVER$$aarticle
001005974 3367_ $$2DataCite$$aOutput Types/Journal article
001005974 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001005974 500__ $$aAvailable online 16 October 2024
001005974 588__ $$aDataset connected to , , , CrossRef, Journals: publications.rwth-aachen.de
001005974 591__ $$aAustralia
001005974 591__ $$aCanada
001005974 591__ $$aGermany
001005974 591__ $$aItaly
001005974 591__ $$aSingapore
001005974 591__ $$aSouth Korea
001005974 591__ $$aSpain
001005974 591__ $$aUK
001005974 591__ $$aUSA
001005974 7001_ $$aMesa, Ruben$$b1
001005974 7001_ $$00000-0003-3361-3981$$aTalpaz, Moshe$$b2
001005974 7001_ $$aGupta, Vikas$$b3
001005974 7001_ $$aGerds, Aaron T.$$b4
001005974 7001_ $$aPerkins, Andrew$$b5
001005974 7001_ $$aGoh, Yeow Tee$$b6
001005974 7001_ $$aFox, Maria Laura$$b7
001005974 7001_ $$aMcLornan, Donal$$b8
001005974 7001_ $$aPalmer, Jeanne$$b9
001005974 7001_ $$aFoltz, Lynda$$b10
001005974 7001_ $$aVannucchi, Alessandro$$b11
001005974 7001_ $$0P:(DE-82)IDM06178$$aKoschmieder, Steffen$$b12$$urwth
001005974 7001_ $$aPassamonti, Francesco$$b13
001005974 7001_ $$aLee, Sung-Eun$$b14
001005974 7001_ $$aEllis, Catherine$$b15
001005974 7001_ $$aStrouse, Bryan$$b16
001005974 7001_ $$aGonzalez Carreras, Francisco J.$$b17
001005974 7001_ $$aOh, Stephen T.$$b18
001005974 773__ $$0PERI:(DE-600)2540998-0$$a10.1016/j.clml.2024.10.001$$n3$$p199-211$$tClinical lymphoma, myeloma & leukemia$$v25$$x2152-2669$$y2025
001005974 8564_ $$uhttps://publications.rwth-aachen.de/record/1005974/files/1005974.pdf$$yOpenAccess
001005974 909CO $$ooai:publications.rwth-aachen.de:1005974$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001005974 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06178$$aRWTH Aachen$$b12$$kRWTH
001005974 9141_ $$y2024
001005974 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001005974 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001005974 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCL LYMPH MYELOM LEUK : 2022$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001005974 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-13
001005974 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-13
001005974 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2 ; 933110$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
001005974 9201_ $$0I:(DE-82)531040-3_20140620$$k531040-3 ; 933210$$lLehr- und Forschungsgebiet Translationale Hämatologie und Onkologie$$x1
001005974 961__ $$c2025-03-10T09:08:21.303029$$x2025-03-10T09:08:21.303029$$z2025-03-10T09:08:21.303029
001005974 9801_ $$aFullTexts
001005974 980__ $$aI:(DE-82)531040-2_20140620
001005974 980__ $$aI:(DE-82)531040-3_20140620
001005974 980__ $$aUNRESTRICTED
001005974 980__ $$aVDB
001005974 980__ $$ajournal